Hypocaloric vs. Full Energy Enteral Feeding in Critically Ill Patients
- Conditions
- Enteral Feeding
- Registration Number
- NCT01665664
- Lead Sponsor
- Wolfson Medical Center
- Brief Summary
Underfeeding in the critically ill patient is a common observable fact throughout intensive care units. Patients who develop caloric deficit during their stay in the ICU have been shown in previous reports to be associated with increased complications such as increased rate of infections, and nosocomial blood stream infections. Yet, other studies have shown that patients with moderate caloric deficit may be associated with better outcome than patients who receive higher levels of caloric intake.
- Detailed Description
Therefore, the aim of our study is to establish the exact amount of calories to be delivered by indirect calorimetry individually for each patient. Thereafter, each patient will be randomized to the trophic group (hypocaloric feeding), or to the full energy delivery group.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
- Anticipated Mechanical ventilation for at least 72 hrs.
- Need for enteral feeding
- men and woman aged 18 or older.
- Abdominal surgery with inability to feed enterally.
- FiO2 greater than 80%
- Bronchopleural fistula
- Hemodynamic instability in spite the use of vassopressors.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method All cause mortality, ICU mortality, Hospital mortality. 1 year All cause mortality, ICU mortality, Hospital mortality.
- Secondary Outcome Measures
Name Time Method ICU and Hospital LOS, Length of mechanical ventilation, rate of infections, 1 year ICU LOS, Hospital LOS, Length of mechanical ventilation, ventilation free days, rate of infections, rate of ventilator associated pneumonia,
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Wolfson MC
🇮🇱Holon, Israel
Wolfson MC🇮🇱Holon, IsraelArie Soroksky, MDPrincipal Investigator